Incannex Healthcare (IXHL) Competitors $0.39 -0.20 (-34.10%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.41 +0.02 (+5.84%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. VNRX, PYXS, BMEA, INCR, PMVP, GNTA, QNTM, TELO, CUE, and AVTXShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include VolitionRx (VNRX), Pyxis Oncology (PYXS), Biomea Fusion (BMEA), InterCure (INCR), PMV Pharmaceuticals (PMVP), Genenta Science (GNTA), Quantum Biopharma (QNTM), Telomir Pharmaceuticals (TELO), Cue Biopharma (CUE), and Avalo Therapeutics (AVTX). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Its Competitors VolitionRx Pyxis Oncology Biomea Fusion InterCure PMV Pharmaceuticals Genenta Science Quantum Biopharma Telomir Pharmaceuticals Cue Biopharma Avalo Therapeutics VolitionRx (NYSE:VNRX) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends. Which has more volatility and risk, VNRX or IXHL? VolitionRx has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.47, indicating that its share price is 647% more volatile than the S&P 500. Is VNRX or IXHL more profitable? Incannex Healthcare has a net margin of 0.00% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets VolitionRx-2,321.14% N/A -163.39% Incannex Healthcare N/A -342.92%-148.64% Do institutionals & insiders have more ownership in VNRX or IXHL? 8.1% of VolitionRx shares are held by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are held by institutional investors. 10.4% of VolitionRx shares are held by company insiders. Comparatively, 15.5% of Incannex Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, VNRX or IXHL? Incannex Healthcare has lower revenue, but higher earnings than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVolitionRx$1.31M50.86-$35.32M-$0.27-2.37Incannex Healthcare$98K115.78-$18.46M-$1.21-0.32 Do analysts recommend VNRX or IXHL? VolitionRx currently has a consensus target price of $3.50, suggesting a potential upside of 446.88%. Given VolitionRx's stronger consensus rating and higher probable upside, equities research analysts plainly believe VolitionRx is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VolitionRx 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Incannex Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer VNRX or IXHL? In the previous week, Incannex Healthcare had 9 more articles in the media than VolitionRx. MarketBeat recorded 9 mentions for Incannex Healthcare and 0 mentions for VolitionRx. Incannex Healthcare's average media sentiment score of 0.05 beat VolitionRx's score of 0.00 indicating that Incannex Healthcare is being referred to more favorably in the news media. Company Overall Sentiment VolitionRx Neutral Incannex Healthcare Neutral SummaryIncannex Healthcare beats VolitionRx on 9 of the 17 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IXHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.22M$2.46B$5.48B$9.51BDividend YieldN/A1.81%4.73%4.09%P/E Ratio-0.328.9728.6723.80Price / Sales115.78437.63373.9066.58Price / CashN/A157.7635.4557.96Price / Book2.144.838.275.55Net Income-$18.46M$31.62M$3.24B$259.03M7 Day Performance-63.29%-5.28%-3.69%-4.59%1 Month Performance86.32%4.38%4.33%4.46%1 Year Performance-78.70%-2.49%25.95%18.03% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.5859 of 5 stars$0.39-34.1%N/A-80.0%$17.22M$98K-0.323News CoverageGap DownVNRXVolitionRx1.4718 of 5 stars$0.68-0.2%$3.50+418.5%-3.5%$70.19M$1.31M-1.8780Gap UpPYXSPyxis Oncology2.1587 of 5 stars$1.13-3.4%$9.00+696.5%-70.2%$70.00M$16.15M-0.7160BMEABiomea Fusion3.1307 of 5 stars$1.85-1.6%$20.10+986.5%-72.7%$69.50MN/A-0.5250Positive NewsINCRInterCureN/A$1.52+1.3%N/A-32.1%$69.27M$66.28M0.00350Gap UpPMVPPMV Pharmaceuticals3.5341 of 5 stars$1.33flat$5.50+313.5%-11.9%$69.09MN/A-1.1350Positive NewsUpcoming EarningsGap DownGNTAGenenta Science1.6585 of 5 stars$3.77-0.3%$25.00+563.1%-13.5%$68.95MN/A0.007Short Interest ↑QNTMQuantum BiopharmaN/A$23.37+3.8%N/AN/A$68.01MN/A-1.46N/AGap DownTELOTelomir Pharmaceuticals3.5632 of 5 stars$2.28+88.4%$15.00+557.9%-49.1%$67.85MN/A-5.431Gap UpHigh Trading VolumeCUECue Biopharma3.8382 of 5 stars$0.90+7.1%$3.00+233.3%-4.9%$67.82M$9.29M-1.3460AVTXAvalo Therapeutics3.058 of 5 stars$6.25+10.4%$30.00+380.0%-28.6%$67.69M$440K0.0040News CoverageHigh Trading Volume Related Companies and Tools Related Companies VolitionRx Alternatives Pyxis Oncology Alternatives Biomea Fusion Alternatives InterCure Alternatives PMV Pharmaceuticals Alternatives Genenta Science Alternatives Quantum Biopharma Alternatives Telomir Pharmaceuticals Alternatives Cue Biopharma Alternatives Avalo Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
